Cisplatin-loaded albumin nanoparticle and study their internalization effect by using β-cyclodextrin

References

• He G, Xie X, Siddik ZH. Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents. Cancer Chemother Pharmacol. 2020;85(6):1129–1140.
   PubMed Web of Science ®Google Scholar
• Wen Q, Zhang Y, Luo J, et al. Therapeutic efficacy of thermosensitive pluronic hydrogel for codelivery of resveratrol microspheres and cisplatin in the treatment of liver cancer ascites. Int J Pharm. 2020; 582:119334.
   PubMedGoogle Scholar
• Gupta S, Pathak Y, Gupta MK, et al. Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted. Artif Cells Nanomed Biotechnol. 2019;47(1):4066–4088.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao L, Qi L, et al. Polymer assembly: Promising carriers as co-delivery systems for cancer therapy. Prog Polym Sci. 2016;58:1–26.
   Web of Science ®Google Scholar
• Saha A, Pradhan N, Chatterjee S, et al. Fatty-amine-conjugated cationic bovine serum albumin nanoparticles for target-specific hydrophobic drug delivery. ACS Appl Nano Mater. 2019;2(6):3671–3683.
   Web of Science ®Google Scholar
• Joshi M, Nagarsenkar M, Prabhakar B. Albumin nanocarriers for pulmonary drug delivery: An attractive approach. J Drug Delivery Sci Technol. 2020;56:101529.
   Web of Science ®Google Scholar
• Zhang J, Zhang D, Li Q, et al. Task-specific design of immune-augmented nanoplatform to enable high-efficiency tumor immunotherapy. ACS Appl Mater Interfaces. 2019;11(46):42904–42916.
   PubMed Web of Science ®Google Scholar
• Reina-Campos M, Diaz-Meco MT, Moscat J. The complexity of the serine glycine one-carbon pathway in cancerSerine biosynthesis in cancer. J Cell Biol. 2020;219(1):1–17.
   Web of Science ®Google Scholar
• Raheel H, Ghaffari S, Khosraviani N, et al. CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery. Am J Physiol Lung Cell Mol Physiol. 2019;316(5):L740–L750.
   PubMed Web of Science ®Google Scholar
• Parodi A, Miao J, Soond SM, et al. Albumin nanovectors in cancer therapy and imaging. Biomolecules. 2019;9(6):218.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kato A, Harashima H. Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomes. Biochem Biophys Res Commun. 2020;525(2):313–318.
   PubMed Web of Science ®Google Scholar
• Tian B, Hua S, Liu J. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review. Carbohydr Polym. 2020;232:115805.
   PubMed Web of Science ®Google Scholar
• Das S, Nath S, Singh TS, et al. Cavity size dependent stoichiometry of probe–cyclodextrin complexation: Experimental and molecular docking demonstration. J Photochem Photobiol, A. 2020;388:112158.
   Web of Science ®Google Scholar
• Ghourab N, Gardouh a, Gad S, et al. Nanosponge as a drug delivery system. Records Pharmaceu Biomed Sci. 2020;4(1):17–31.
   Google Scholar
• Allahyari S, Trotta F, Valizadeh H, et al. Cyclodextrin-based nanosponges as promising carriers for active agents. Expert Opin Drug Deliv. 2019;16(5):467–479.
   PubMed Web of Science ®Google Scholar
• Feltes M, Gale SE, Moores S, et al. Monitoring the itinerary of lysosomal cholesterol in Niemann-Pick Type C1-deficient cells after cyclodextrin treatment. J Lipid Res. 2020;61(3):403–412.
   PubMed Web of Science ®Google Scholar
• Hammoud Z, Khreich N, Auezova L, et al. Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance. Int J Pharm. 2019;564:59–76.
   PubMedGoogle Scholar
• Bernatchez P. Endothelial caveolin and its scaffolding domain in cancer. Cancer Metastasis Rev. 2020;39(2):471–483.
   PubMed Web of Science ®Google Scholar
• Lu C-C, Wang G-H, Lu J, et al. Role of podocyte injury in glomerulosclerosis. In: Renal fibrosis: Mechanisms and therapies. Singapore: Springer; 2019. p. 195–232.
   Google Scholar
• Singh V, Lamaze C. Membrane tension buffering by caveolae: a role in cancer? Cancer Metastasis Rev. 2020;39(2):505–517.
   PubMed Web of Science ®Google Scholar
• Ruseska I, Zimmer A. Internalization mechanisms of cell-penetrating peptides. Beilstein J Nanotechnol. 2020;11(1):101–123.
   PubMedGoogle Scholar
• Arriagada F, Günther G, Zabala I, et al. Development and characterization of florfenicol-loaded BSA nanoparticles as controlled release carrier. AAPS PharmSciTech. 2019;20(5):202
   PubMed Web of Science ®Google Scholar
• Abreu AS, Carvalho JA, Trindade AC, et al. Synthesis, photophysical and photobiological characterization of BSA nanoparticles loaded with chloroaluminium phthalocyanine by one-step desolvation technique for photodynamic therapy action. J Biomater Sci Polym Ed. 2019;30(16):1559–1573.
   PubMed Web of Science ®Google Scholar
• Ferrado JB, Perez AA, Visentini FF, et al. Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems. Colloids Surf B Biointerfaces. 2019;173:43–51.
   PubMed Web of Science ®Google Scholar
• Wang H, Sun S, Zhang Y, et al. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles. Drug Deliv. 2019;26(1):89–97.
   PubMed Web of Science ®Google Scholar
• Salehiabar M, Nosrati H, Javani E, et al. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol. 2018;115:83–89.
   PubMed Web of Science ®Google Scholar
• Choi J-S, Meghani N. Impact of surface modification in BSA nanoparticles for uptake in cancer cells. Colloids Surf B Biointerfaces. 2016;145:653–661.
   PubMed Web of Science ®Google Scholar
• Lee SH, Song JG, Han H-K. Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugs. J Control Release. 2019;311-312:74–84.
   PubMed Web of Science ®Google Scholar
• Amani S, Mohamadnia Z, Mahdavi A. pH-responsive hybrid magnetic polyelectrolyte complex based on alginate/BSA as efficient nanocarrier for curcumin encapsulation and delivery. Int J Biol Macromol. 2019;141:1258–1270.
   PubMed Web of Science ®Google Scholar
• Karami K, Jamshidian N, Hajiaghasi A, et al. BSA nanoparticles as controlled release carriers for isophethalaldoxime palladacycle complex; synthesis, characterization, in vitro evaluation, cytotoxicity and release kinetics analysis. New J Chem. 2020;44(11):4394–4405.
   Web of Science ®Google Scholar
• Kim IY, Shim MJ, Lee DM, et al. Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death. Biochem Pharmacol. 2019;162:41–54.
   PubMed Web of Science ®Google Scholar
• Li H, Chen H, Li R, et al. Cucurbitacin I induces cancer cell death through the endoplasmic reticulum stress pathway. J Cell Biochem. 2019;120(2):2391–2403.
   Web of Science ®Google Scholar
• Farasat A, Rahbarizadeh F, Ahmadvand D, et al. Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin. J Liposome Res. 2019;29(1):53–65.
   PubMed Web of Science ®Google Scholar
• Amighi F, Emam-Djomeh Z, Labbafi-Mazraeh-Shahi M. Effect of different cross-linking agents on the preparation of bovine serum albumin nanoparticles. J Iran Chem Soc. 2020;17(5):1213–1223.
   Web of Science ®Google Scholar
• Sripriyalakshmi S, Anjali CH, George PDC, et al. BSA nanoparticle loaded atorvastatin calcium-a new facet for an old drug. PLoS One. 2014;9(2):e86317
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar
• Rahimnejad M, Najafpour G, Bakeri G. Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier. Colloids Surf, A. 2012;412:96–100.
   Web of Science ®Google Scholar
• Corinti D, Coletti C, Re N, et al. Cisplatin binding to biological ligands revealed at the encounter complex level by IR action spectroscopy. Chemistry. 2016;22(11):3794–3803.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Katoh S, Nakajima M, et al. FT-IR analysis of BSA fouled on ultrafiltration and microfiltration membranes. J Membrane Sci. 2001;192(1-2):201–207.
   Web of Science ®Google Scholar
• Boi S, Rouatbi N, Dellacasa E, et al. Alginate microbeads with internal microvoids for the sustained release of drugs. Int J Biol Macromol. 2020;156:454–461.
   PubMed Web of Science ®Google Scholar
• Merodio M, Arnedo A, Renedo MJ, et al. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci. 2001;12(3):251–259.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang N, Ma T, et al. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release. Drug Deliv. 2020;27(1):1156–1164.
   PubMed Web of Science ®Google Scholar
• Zuhorn IS, Kalicharan R, Hoekstra D. Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J Biol Chem. 2002;277(20):18021–18028.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Garcion E, et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond). 2010;5(2):287–306.
   PubMed Web of Science ®Google Scholar